154 related articles for article (PubMed ID: 33857838)
21. Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study.
Kawai M; Murakami Y; Motoi F; Sho M; Satoi S; Matsumoto I; Honda G; Hirono S; Okada K; Unno M; Nakajima Y; Uemura K; Kwon AH; Fukumoto T; Kurata M; Yamaue H
Surgery; 2016 Aug; 160(2):293-305. PubMed ID: 27083480
[TBL] [Abstract][Full Text] [Related]
22. Postoperative complications and survival rates for pancreatic cancer patients.
Kaťuchová J; Bober J; Radoňak J
Wien Klin Wochenschr; 2011 Feb; 123(3-4):94-9. PubMed ID: 21253778
[TBL] [Abstract][Full Text] [Related]
23. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis.
Uchida Y; Masui T; Nagai K; Anazawa T; Yoshimura M; Uza N; Takaori K; Mizowaki T; Uemoto S
Surg Oncol; 2020 Dec; 35():527-532. PubMed ID: 33160278
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
Conlon KC; Klimstra DS; Brennan MF
Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
[TBL] [Abstract][Full Text] [Related]
25. Surgical experience with pancreatic and periampullary cancer.
Herter FP; Cooperman AM; Ahlborn TN; Antinori C
Ann Surg; 1982 Mar; 195(3):274-81. PubMed ID: 6277259
[TBL] [Abstract][Full Text] [Related]
26. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
[No Abstract] [Full Text] [Related]
27. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
28. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis.
Mackay TM; Smits FJ; Roos D; Bonsing BA; Bosscha K; Busch OR; Creemers GJ; van Dam RM; van Eijck CHJ; Gerhards MF; de Groot JWB; Groot Koerkamp B; Haj Mohammad N; van der Harst E; de Hingh IHJT; Homs MYV; Kazemier G; Liem MSL; de Meijer VE; Molenaar IQ; Nieuwenhuijs VB; van Santvoort HC; van der Schelling GP; Stommel MWJ; Ten Tije AJ; de Vos-Geelen J; Wit F; Wilmink JW; van Laarhoven HWM; Besselink MG;
HPB (Oxford); 2020 Feb; 22(2):233-240. PubMed ID: 31439478
[TBL] [Abstract][Full Text] [Related]
29. Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcomes of Curative Intent Surgery: A Study of the French Surgical Association.
Lupinacci RM; Faron M; Bachellier P; Sauvanet A; Beauchet A; Le Treut YP; Adham M; Mabrut JY; Delpero JR; Paye F
World J Surg; 2021 Oct; 45(10):3146-3156. PubMed ID: 34191085
[TBL] [Abstract][Full Text] [Related]
30. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Klompmaker S; van Hilst J; Gerritsen SL; Adham M; Teresa Albiol Quer M; Bassi C; Berrevoet F; Boggi U; Busch OR; Cesaretti M; Dalla Valle R; Darnis B; De Pastena M; Del Chiaro M; Grützmann R; Diener MK; Dumitrascu T; Friess H; Ivanecz A; Karayiannakis A; Fusai GK; Labori KJ; Lombardo C; López-Ben S; Mabrut JY; Niesen W; Pardo F; Perinel J; Popescu I; Roeyen G; Sauvanet A; Prasad R; Sturesson C; Lesurtel M; Kleeff J; Salvia R; Besselink MG;
Ann Surg Oncol; 2018 May; 25(5):1440-1447. PubMed ID: 29532342
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.
Powers BD; Fulp W; Dhahri A; DePeralta DK; Ogami T; Rothermel L; Permuth JB; Vadaparampil ST; Kim JK; Pimiento J; Hodul PJ; Malafa MP; Anaya DA; Fleming JB
Ann Surg; 2021 Dec; 274(6):e564-e573. PubMed ID: 31851004
[TBL] [Abstract][Full Text] [Related]
32. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study.
Lovecek M; Skalicky P; Klos D; Bebarova L; Neoral C; Ehrmann J; Zapletalova J; Svebisova H; Vrba R; Stasek M; Yogeswara T; Havlik R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):280-6. PubMed ID: 27029600
[TBL] [Abstract][Full Text] [Related]
34. The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.
Wu W; He J; Cameron JL; Makary M; Soares K; Ahuja N; Rezaee N; Herman J; Zheng L; Laheru D; Choti MA; Hruban RH; Pawlik TM; Wolfgang CL; Weiss MJ
Ann Surg Oncol; 2014 Sep; 21(9):2873-81. PubMed ID: 24770680
[TBL] [Abstract][Full Text] [Related]
35. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study.
Åkerberg D; Björnsson B; Ansari D
Scand J Gastroenterol; 2017 Jan; 52(1):56-60. PubMed ID: 27598522
[TBL] [Abstract][Full Text] [Related]
37. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
38. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
[TBL] [Abstract][Full Text] [Related]
39. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
Lewis R; Drebin JA; Callery MP; Fraker D; Kent TS; Gates J; Vollmer CM
HPB (Oxford); 2013 Jan; 15(1):49-60. PubMed ID: 23216779
[TBL] [Abstract][Full Text] [Related]
40. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
